CyberKnife radiation for early kidney cancer
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests whether CyberKnife (high-precision radiation) can treat early-stage kidney cancer. It may help people avoid or delay more invasive treatments by targeting the tumor while protecting nearby organs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have confirmed stage I kidney cancer (T1N0M0) that is 8 cm or smaller
- You can have gold tracking markers (fiducials) placed near or in the tumor
- You are 18 or older, with no known study dose information for children
- You can get CT and/or MRI scans for planning within the last 120 days
- Your general health is good enough (ECOG 0–2) and you have at least 12 months life expectancy
- Your blood work and clotting tests are within safe limits for the marker placement and radiation planning
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of targeted radiation therapy with a restart of immunotherapy for people whose kidney cancer has grown after prior immunotherapy. It aims to see if radiation can help the immune system fight the cancer again.
This trial tests a precise type of radiation called stereotactic body proton therapy for people with kidney cancer who cannot have surgery or other local treatments. It aims to see if this focused radiation can control the tumor with fewer side effects.
This trial tests whether giving a higher radiation dose to some tumors can help control kidney cancer that has spread to other parts of the body. It is for people who cannot have surgery to remove these tumors and are already receiving other treatments.
This trial tests a high-precision radiation treatment (CyberKnife SBRT) for prostate cancer that is still within the prostate. It aims to see if a very short course of radiation works well with fewer side effects.
This trial studies how safe CyberKnife is when used to treat some borderline resectable or locally advanced pancreatic cancers after chemotherapy. It may help patients by targeting the tumor with precise radiation, while researchers closely watch for side effects.
This trial tests a new way to deliver radiation to kidney tumors using MRI guidance. It aims to treat early-stage kidney cancer while sparing healthy tissue, and may be an option for people who cannot have surgery or prefer not to.
Hear when a new Renal Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.